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Abstract
Measles viruses (MV) can be isolated from the brains of deceased subacute sclerosing panencephalitis
patients only in a cell-associated form. These viruses are often defective in the matrix (M) protein and
always seem to have an altered fusion protein cytoplasmic tail. We reconstituted a cell-free, infectious
M-less MV (MV-DeltaM) from cDNA. In comparison with standard MV, MV-DeltaM was
considerably more efficient at inducing cell-to-cell fusion but virus titres were reduced approximately
250-fold. In MV-DeltaM-induced syncytia the ribonucleocapsids and glycoproteins largely lost
co-localization, confirming the role of M protein as the virus assembly organizer. Genetically modified
mice were inoculated with MV-DeltaM or with another highly fusogenic virus bearing glycoproteins
with shortened cytoplasmic tails (MV-Delta(tails)). MV-DeltaM and MV-Delta(tails) lost acute
pathogenicity but penetrated more deeply into the brain parenchyma than standard MV. We suggest that
enhanced cell fusion may also favour the propagation of mutated, assembly-defective MV in human
brains.
The EMBO Journal Vol.17 No.14 pp.3899–3908, 1998
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Measles viruses (MV) can be isolated from the brains of
deceased subacute sclerosing panencephalitis patients
only in a cell-associated form. These viruses are often
defective in the matrix (M) protein and always seem
to have an altered fusion protein cytoplasmic tail. We
reconstituted a cell-free, infectious M-less MV (MV-
∆M) from cDNA. In comparison with standard MV,
MV-∆M was considerably more efficient at inducing
cell-to-cell fusion but virus titres were reduced ~250-
fold. In MV-∆M-induced syncytia the ribonucleo-
capsids and glycoproteins largely lost co-localization,
confirming the role of M protein as the virus assembly
organizer. Genetically modified mice were inoculated
with MV-∆M or with another highly fusogenic virus
bearing glycoproteins with shortened cytoplasmic tails
(MV-∆tails). MV-∆M and MV-∆tails lost acute patho-
genicity but penetrated more deeply into the brain
parenchyma than standard MV. We suggest that
enhanced cell fusion may also favour the propagation
of mutated, assembly-defective MV in human brains.
Keywords: cell-to-cell fusion/envelope protein
cytoplasmic tail/matrix protein/subacute sclerosing
panencephalitis/virus assembly
Introduction
Subacute sclerosing panencephalitis (SSPE) is one of
the most thoroughly studied neurodegenerative diseases
caused by persistent viral infection of the human central
nervous system (CNS), and serves as a model for the
analysis of persistent viral infections causing other human
syndromes (Kristensson and Norrby, 1986). SSPE gener-
ally develops 5–10 years after acute measles virus (MV)
infection, starting with subtle intellectual and psycholo-
gical dysfunction and progressing to motor and sensory
deterioration, cerebral degeneration and death within
months or years (ter Meulen et al., 1983). MV is a non-
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integrating negative-strand RNA virus which consists of
a replicative unit, the ribonucleocapsid and an envelope.
The envelope contains two integral membrane proteins,
fusion (F) and haemagglutinin (H), and a membrane-
associated matrix (M) protein that contacts the ribonucleo-
capsid (Hirano et al., 1993), as well as the cytoplasmic
tail of the F protein (Cathomen et al., 1998; Spielhofer
et al., 1998).
A typical SSPE feature is the failure of persistently
infected brain cells to produce progeny virus particles (ter
Meulen et al., 1983). Since defects in M are very common
in SSPE (Cattaneo et al., 1988) and M-defective MV
genomes expand clonally in the CNS (Baczko et al.,
1993), it has been postulated that M is dispensable for
virus replication and spread in human brain, and that
abrogation of M protein function accounts for lack of
particle formation and may favour virus persistence. More
recently, it has been shown that the cytoplasmic tail of
the F protein is altered in all SSPE viruses analysed so
far (Schmid et al., 1992). This suggests that a common
prerequisite for SSPE may not be solely the loss of
M protein function, but more generally any alteration
interfering with envelope assembly (Billeter and Cattaneo,
1991; Griffin and Bellini, 1996). Recently, it has been
shown that engineered MVs with altered F and H glycopro-
tein cytoplasmic tails gain cell-to-cell fusion competence
(Cathomen et al., 1998), suggesting that these interactions
may be involved not only in virus assembly, but also in
virus-induced cell fusion.
Taken together, these observations suggest links between
loss of proper MV particle assembly and extensive cell
fusion, virus spread in the CNS and brain pathogenesis.
Up until now, the mechanisms connecting these events
could not be tested experimentally for two reasons. First,
M-defective, cell-free virus was not available. Secondly,
comparative analysis of the neuropathogenesis of different
MV strains was possible only in primates (van Binnendijk
et al., 1995), as newborn rodents were susceptible only
to neuroadapted MV (Liebert and Finke, 1995). Recently,
however, newborn mice expressing the main MV receptor
CD46 in neural cells (Rall et al., 1997) and adult animals
expressing CD46 with human-like tissue specificity and
defective for the interferon type I receptor (Mrkic et al.,
1998) were found to support the brain spread of neurotropic
as well as attenuated MV strains.
An M-less MV (MV-∆M) was generated here using a
modified cDNA copy of the negative-strand RNA genome
of the Edmonston B vaccine strain (Radecke et al., 1995).
The propagation of this virus was compared with that of
the standard (Edmonston) MV in cultured cells. Moreover,
the spread and pathogenesis of the M-less MV, the standard
MV and a virus bearing F and H proteins with shortened
cytoplasmic tails was analysed after intracerebral inocula-
tion of genetically modified mice (Mrkic et al., 1998).
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Results
An M-less MV is infectious and highly fusogenic
In an attempt to generate an M-less virus, an MV
antigenomic cDNA, p(1)MV-∆M, was constructed that
contained a 960 nucleotide deletion in the M-coding
region (Figure 1A, centre). Plasmid p(1)MV-∆M and
the control plasmid p(1)MV (Figure 1A, top), which
gives rise to a standard sequence-tagged Edmonston B
MV, were used in separate experiments to transfect the
helper cell line 293-3-46 (Radecke et al., 1995). After
3–5 days syncytia were observed, suggesting rescue of
infectivity.
The identity of this infectivity was verified by
M-gene-specific reverse transcription–PCR (RT–PCR)
(Figure 1B). The DNA amplification product obtained
from MV-∆M-infected cells was 960 nucleotides shorter
than that obtained from standard MV-infected cells
(Figure 1B, compare lane 6 with lane 3) and was the
same size as the control product derived from the
p(1)MV-∆M DNA (Figure 1B, lane 4). In both cases,
a control amplification over the N gene yielded the
expected 475 nucleotide fragment (Figure 1B, lanes 9
and 12). When reverse transcriptase was omitted from
the reactions (Figure 1B, lanes 2, 5, 8 and 11), no
product could be detected indicating that the DNA
products obtained in lanes 3, 6, 9 and 12 were not due
to amplification from the remaining cDNA plasmids but
to amplification from an RNA template.
To further characterize the infection, protein extracts
of 35S-methionine pulse-labelled MV-∆M-infected, MV-
infected or mock-infected Vero cells were immunopre-
cipitated with an anti-MV antibody and separated by
gel electrophoresis (Figure 1C). The viral H and
nucleocapsid (N) proteins were monitored in both cells
infected with MV (Figure 1C, lane 3) and with MV-
∆M (Figure 1C, lane 7), and only standard MV-infected
cells (Figure 1C, lane 3) but not MV-∆M-infected cells
(Figure 1C, lane 7) produced M protein.
Since M protein may bridge the encapsidated viral
RNA genomes with the two integral membrane proteins
H and F, it may also influence their transport within
the infected cell. Intracellular transport was analysed by
comparing the glycosylation state of the H protein in
MV-infected cells with that in MV-∆M-infected cells,
immediately or 4 h after 1 h pulse-labelling. In both
MV-infected cells (Figure 1C, lanes 5 and 6) and MV-
∆M-infected cells (Figure 1C, lanes 9 and 10) a large
fraction of the H protein became partially endo H
resistant 4 h after synthesis (Figure 1C, triangles in
lanes 6 and 10), suggesting passage through the medial-
Golgi. The H protein intracellular transport is therefore
influenced only slightly, if at all, by the absence of M-
protein expression.
Microscopic observation of infected cells revealed
that at any given time the MV-∆M syncytia were
considerably larger than the standard MV syncytia
(Figure 2A–F; for two average syncytia). In standard
MV infections numerous secondary infection centres
formed starting at day 3 (Figure 2B and C, arrows),
whereas in MV-∆M infections secondary syncytia were
very rare (Figure 2F, arrowhead). Quantification of the
extent of cell fusion after infection with a multiplicity
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Fig. 1. Generation and analysis of an M-less MV. (A) Structure of MV
antigenomic cDNAs encoding standard (top) or mutant (bottom)
viruses. The MV genomes of plasmid p(1)MV (Radecke et al., 1995),
p(1)MV-∆M and p(1)MV-∆tails are shown. The black boxes represent
the reading frames of the six MV cistrons N, P, M, F, H and L. The
structure of the subcloning intermediate peP∆MF2 is depicted with the
relevant restriction enzyme sites (centre) and the predicted protein
sequence of M and ∆M proteins above it. For M, only the terminal
amino acids are indicated. Nucleotide numbering is according to
DDBJ/EMBL/GenBank accession No. Z66517. aa, amino acids.
(B) RT–PCR analysis of MV and MV-∆M virus genomes. Template
RNAs for the amplifications shown in lanes 2, 3, 8 and 9 were from
MV-infected cells, template RNAs for the amplifications shown in
lanes 5, 6, 11 and 12 were from MV-∆M-infected cells. Reverse
transcriptase was omitted in the reactions of lanes 2, 5, 8 and 11
(mock). A control reaction based on plasmid DNA is shown in lanes
1, 4, 7 and 10. On the left the M and ∆M genes and on the right the
N gene, respectively, are shown schematically with the amplification
primers. (C) Immunoprecipitation of pulse-labelled MV proteins from
MV- and MV-∆M-infected cells. Proteins in lanes 1 and 2 were
precipitated from mock-infected Vero cells, in lanes 3–6 from
MV-infected cells and in lanes 7–10 from MV-∆M-infected cells. The
presence (1) or absence (–) of endo H in the glycosidase digestion
and the length of the chase time (0 or 4 h) are indicated on the top.
The positions of H, N and M proteins are indicated on the left, the
size markers are on the right.
A matrix-less measles virus
Fig. 2. Characteristics of MV-∆M infection of Vero cells. (A–F) Syncytia growth on MV- or MV-∆M-infected Vero cells. After infection with an
m.o.i. of 0.001, MV-induced syncytia (A–C) and MV-∆M-induced syncytia (D–F) were monitored by phase-contrast microscopy at 2 days (A, D),
3 days (B, E) and 4 days (C, F) p.i. The arrows (B, C) and arrowhead (F) indicate secondary infection centres. (G, H) Time course of virus
production of MV-infected or MV-∆M-infected Vero cells. After infection with an m.o.i. of 0.01 virus titres were determined by 50% end-point
dilution at the indicated time points. The titre of cell-associated infectivity is indicated by solid circles (G, MV) or diamonds (H, MV-∆M), and that
of released virus by open circles or diamonds, respectively. The average of two independent experiments is shown. TCID50, tissue culture infectious
dose 50; p.i. post-infection.
of infection (m.o.i.) of 0.01 revealed that after 4 days
~75% of the nuclei of an MV-∆M-infected cell monolayer
were in syncytia, compared with ~25% of the nuclei
of MV-infected cells. After 6 days, .90% of the cells
were involved in syncytia in both MV and MV-∆M
infections, and cell mortality was substantial. These data
indicate that the M-less virus is more efficient than
standard MV at inducing cell-to-cell fusion; at later
stages, the formation of secondary infectious centres
allows standard MV to compensate for the initial delay.
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An M-less MV is assembly defective
The production of infectivity was then followed after
inoculating Vero cells with an m.o.i. of 0.01. Both cell-
associated and supernatant infectivity were measured at
1 day intervals. The growth curves indicated that MV-∆M
infections (Figure 2H) produced a maximum of 5500
tissue culture infectious dose 50 (TCID50)/ml 3 days after
infection. Cell-free infectivity reached a maximum of 360
TCID50/ml 5 days after infection. In the parallel standard
MV infections (Figure 2G) the titres of cell-associated
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Fig. 3. Distribution of viral proteins in infected Vero cells. Two to three days after infection cells were permeabilized and stained with H-, M- or
P-specific antibodies. Immunoreactivity was detected by confocal microscopy. Each micrograph represents a 0.4 µm optical section of syncytia found
after infection with MV (A–C, G–I) or MV-∆M (D–F, J–L). Images show the localization of H protein in red (A, D, G, J), and of M (B, E) or
P protein (H, K) in green. In superimposed pictures co-localization of two proteins is displayed in yellow (C, F, I, L). In (C) putative assembly sites
situated intracellularly (arrowhead) or below the cell surface (arrow) are indicated. The bars represent 20 µm.
and cell-free virus peaked 5 days post-infection (p.i.) at
1.43106 and 83104 TCID50/ml, respectively. Thus the
ratio of released to cell-associated infectivity was similarly
low in standard and MV-∆M infections, but titres of MV-
∆M were reduced ~250 times. Characterization of released
MV-∆M virus infectivity on sucrose gradients was
attempted but failed (see Discussion).
To gain further insight into MV-∆M infections, the
cellular distribution of viral proteins was characterized
using confocal microscopy. Syncytia with ~30 nuclei
monitored in a standard MV infection (A–C and G–I) or
in a MV-∆M infection (D–F and J–L) are shown in Figure
3. In a standard MV infection the H protein (Figure 3A),
the F protein (not shown) and the M protein (Figure 3B)
were concentrated in bright patches. Superimposition of
the M and H images indicated co-localization of the
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two proteins in these patches (Figure 3C) as monitored
intracellularly (arrowhead) and at the cell surface (arrow).
However, in MV-∆M infections no M protein was produced
(Figure 3E) and the H protein was distributed more
homogeneously within the cell and on the cell surface
(Figure 3D). Similarly, in standard MV infections the
H protein (Figure 3G) and the phosphoprotein (P;
Figure 3H) or the N protein (not shown), both constituents
of the ribonucleocapsid, co-localized in bright patches
(Figure 3I). In MV-∆M infections the P protein was
distributed more homogeneously (Figure 3K) and co-
localization with the H protein was less frequent
(Figure 3L).
The structure of MV- and MV-∆M-infected cells was
also examined at higher resolution by electron microscopy.
In Vero cells infected with standard MV, protruding
A matrix-less measles virus
Fig. 4. Electron microscopy of infected Vero cells and viral particles. Vero cells were infected with standard MV (A, C, E) or MV-∆M
(B, D, F, G) with an m.o.i. of 0.05. After 2 days at 32.5°C, F protein (A, B, E) or H protein (C, D, F, G) was detected by indirect immunogold
labelling using a pool of F- or H-specific monoclonal antibodies and colloidal-gold-coupled goat anti-mouse antibodies. (A–D) display characteristic
portions of the infected cell surface. The arrows in A and C point to ribonucleocapsid filaments (18 nm thick). The arrowheads in C and D point to
filaments of the cytoskeleton. (E–G) display virus-like particles observed near cells infected with standard MV (E) or with MV-∆M (F, G).
E, extracellular space; C, cytoplasm; Nu, nucleus; M, membrane. The bar length is indicated.
structures enriched with viral envelope proteins
(Figure 4A, immunogold-labelled for F protein) were
observed frequently along the infected cell surface. Label-
ling of the viral-glycoprotein-enriched areas often coin-
cided with electron-dense filaments apparent beneath the
cell surface. At a higher magnification (Figure 4C, labelling
for H protein), 18 nm thick ribonucleocapsid filaments
could be visualized clearly within such structures (arrows),
indicating that the concentration of the viral glycoproteins
is higher in membrane regions overlaying the ribonucleo-
capsids.
In contrast to MV-infected cells, the surface of cells
infected with MV-∆M did not display characteristic bud-
ding particles although dispersed immunogold labelling
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of the glycoproteins was apparent (Figure 4B and D,
labelling for F and H protein, respectively). Moreover, in
areas where surface labelling of viral glycoproteins was
higher, ribonucleocapsid filaments did not accumulate
(Figure 4D) although overall the same amount of viral
ribonucleocapsids accumulated in the cytoplasm of cells
infected with standard MV or MV-∆M, respectively (not
shown). Only on rare occasions were virus-like particles
detected near cells infected with MV-∆M (Figure 4F and
G). Some of these particles (Figure 4F) were reminiscent
of standard MV (Figure 4E) considering both their size
and the fringe of surface spikes. Most of them, however,
could be merely cell fragments that had detached because
of cell damage due to the infection (Figure 4G). Taken
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Fig. 5. Mortality of genetically modified mice after MV intracerebral inoculation. Six to eight-week-old genetically modified mice were infected
with 106 p.f.u. (A), 105 p.f.u. (B) or 33103 p.f.u. (C) of standard MV (d), MV-∆M (r), or MV-∆tails (m). The number of infected animals are:
(A) n 5 18 for MV, n 5 5 for MV-∆tails; (B) n 5 13 for MV, n 5 12 for MV-∆tails; (C) n 5 8 for MV and MV-∆tails, n 5 9 for MV-∆M.
together, the microscopic analyses indicated that the viral
glycoproteins and the ribonucleocapsids often co-localize
below the plasmalemma in standard MV infections. In
MV-∆M infections the glycoproteins are distributed more
homogeneously and ribonucleocapsids do not concentrate
below the cell surface.
Brain pathogenesis of highly fusogenic/assembly-
defective MV
To ascertain the pathogenic effects of MV-∆M, we infected
intracerebrally 6- to 8-week-old mice expressing the
human receptor CD46 and defective for the interferon
type I system (Mrkic et al., 1998). Since MV-∆M reached
only low titres, we also analysed the pathogenesis of
another virus, MV-∆tails (Figure 1A, bottom), which is
partially defective in envelope assembly and highly fuso-
genic owing to shortened F and H cytoplasmic tails
(formerly named MV-Hc∆14/Fc∆24; Cathomen et al.,
1998).
No significant difference in the lethality of MV and
MV-∆tails was evident following the inoculation of adult
mice with a high dose of virus (106 plaque forming units,
p.f.u.): ~90% of standard MV-infected animals died
3–9 days p.i., whereas ~80% of MV-∆tails-infected mice
died 5–9 days p.i. (Figure 5A). All affected animals showed
clinical signs of neurologic disease: initial hyperactivity
followed by mild ataxic gait, hunchback, occasional epilep-
tic seizures, lethargy and death.
When less virus was applied (105 p.f.u.; Figure 5B), a
difference between MV- and MV-∆tails infections became
apparent: whereas ,10% of MV-∆tails-infected mice died,
the mortality for standard MV-infected mice remained
~90%. Inoculation with 3000 p.f.u. confirmed this tend-
ency (Figure 5C): the mortality dropped to 0 for MV-
∆tails-infected animals but seven out of eight standard
MV-infected mice died 5–27 days p.i. Similarly, only one
of nine animals infected with 3000 p.f.u. of MV-∆M (the
highest dose in a feasible injection volume) died. Surviving
animals monitored for up to 8 months p.i. did not show
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any clinical sign of late neurologic disease. Taken together,
these data indicate that assembly-defective MV mutants
are less pathogenic than standard MV in an acute brain
infection.
To follow the course of brain infection, mice inoculated
with 3000 p.f.u. of any of the three above viruses at
different times p.i. (3 days to 16 weeks) were sacrificed.
Coronal and sagittal brain sections of 24 mouse brains
were examined histologically either directly by staining
with haematoxylin/eosin (HE) and luxol/nuclear fast red
to monitor inflammatory cells and myelin fibres, respect-
ively, or after immunohistochemical processing for glial
fibrillary acidic protein (GFAP) to reveal reactive astrocytic
gliosis. In addition, brain sections were analysed by in
situ hybridization using an MV N-mRNA-specific probe.
A selection of the most informative data obtained at 14
days p.i. is shown in Figure 6. Infectious centres were
detected in different regions of the brain parenchyma
including the frontal part of the cerebrum, the hippocam-
pus, the corpus callosum and the adjacent neocortex, the
hypothalamus and the pons. No clearcut difference in the
extent of viral replication was monitored in MV-∆M and
standard MV infections since the number of infectious
centres detected was limited. In general, strong encephal-
itis, attested by extensive inflammatory infiltrations
(Figure 6D, hypothalamus) and haemorrhage combined
with massive gliosis (Figure 6E), became evident at sites
of virus replication (Figure 6F, MV-∆M). Moreover, virus
(Figure 6I, standard MV) replicating in myelin-rich areas
caused massive inflammation leading to focal demy-
elination (Figure 6G, corpus callosum) and strong gliosis
(Figure 6H).
Besides these common features, important differences
were monitored when comparing GFAP-immunostained
sections of standard MV-infected mouse brains with
MV-∆M- or MV-∆tails-infected mouse brains. Whereas
neuronal cell loss predominated in the hippocampal pyram-
idal cell ribbon (CA1 region, extending between the
arrowheads in Figure 6B) in all of the four standard
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Fig. 6. Histopathological analysis of infected mouse brains. Mice were sacrificed 2 weeks after intracerebral inoculation with 3000 p.f.u. of standard
MV (A, G–I), MV-∆tails (B), or MV-∆M (C–F). Brain sections were immunostained for GFAP (A–C, E, H), or stained directly with haematoxylin/
eosin (D) or luxol/nuclear fast red (G). Virus replication was detected by in situ hybridization with an MV N-mRNA-specific probe (F, I).
Microphotographs show similar segments of the hippocampus/corpus callosum area of standard MV (A, 403) or MV-∆tails (B, 403) infected brains
and a fragment of the thalamus of an MV-∆M-infected brain (C, 503). Comparative analysis of an MV-∆M-infected hypothalamus (D–F, 1323)
monitored extensive inflammatory infiltration (D) and massive gliosis (E) in an area of virus replication (F). In myelin-fibre-rich areas (blue
staining), as shown for a corpus callosum segment infected with standard MV (G–I, 1603), inflammation in combination with focal demyelination
(G) and strong gliosis (H) were detected in an area of virus replication (I).
MV-infected brains analysed (Figure 6A, hippocampus),
only one of eight MV-∆M-infected brains and nought out
of six MV-∆tails-infected brains (Figure 6B) revealed a
similar pathology. Rather, in MV-∆M-infected and MV-
∆tails-infected mice multiple immunoreactive centres were
distributed over the whole brain (Figure 6C, thalamus
region). Thus these analyses indicated that MV-∆M and
MV-∆tails lost almost completely, not only pathogenicity
(Figure 5), but also the capacity to eliminate specifically
cells in the CA1 region of the hippocampal pyramidal
ribbon (Figure 6B). Nevertheless, highly fusogenic/assem-
bly-defective MV infections penetrated more deeply into
the brain parenchyma than standard virus infections
(Figure 6C).
The other data can be summarized as follows: early
(3–7 days) brain sections revealed virus replication in
combination with multifocal meningitis and mild general
inflammation. In addition, limited gliosis was detected in
the hippocampus. Later (5 or 16 weeks), only samples
from MV-∆M or MV-∆tails animals were available, because
standard MV-infected mice succumbed. In these samples
MV replication was no longer detectable by in situ RNA
analysis but clinical signs such as cell sclerosis, that is
cerebral neuronal degeneration followed by invasion of
glial cells and scar tissue, were prominent. Gliosis was
still apparent but became progressively weaker. In sum-
mary, the combined histological and in situ hybridization
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data indicate that standard MV as well as MV-∆M spread
through the brain, attesting that M protein is dispensable
for spreading in the CNS. Nevertheless, the pathogenicity
and mode of propagation of MV-∆M were characteristic-
ally different from those of standard MV, and similar to
those of MV-∆tails.
Discussion
It is shown here that M, a major MV structural protein,
is not absolutely required for virus spread. Remarkably,
an M-less MV switches mode of propagation: whereas
formation of cell-free infectivity is very inefficient, fusion
of MV-∆M infected cells with neighbouring cells is
enhanced. Consistent with this, the highly fusogenic/
assembly-defective M-less virus propagates more deeply
in the brain parenchyma of genetically modified mice than
standard MV.
M protein function: virus assembly
The M protein of paramyxoviruses is believed to play a
central role in virus assembly by coordinating the inter-
actions of the viral components and the cytoskeleton at
internal cell membranes (Peeples, 1991; Sanderson et al.,
1995). Assembly is completed beneath the plasmalemma,
from whence particles bud. In cultured cells, production
of infectious particles is considerably less efficient for
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MV than for other paramyxoviruses: on the one hand,
under optimal conditions 50 cell-associated and five cell-
free infectious particles/cell can be recovered (Udem,
1984; Cattaneo et al., 1987); on the other hand, more
numerous cell-associated particles can be visualized by
electron microscopy (Bohn et al., 1983; Figure 4).
In the parallel standard MV infections of Figure 2G an
average of seven cell-associated infectious particles per
cell were formed, and fewer than one per cell was released.
In MV-∆M infections only one infectious unit per 40
cells was formed, and one per 500 cells was released
(Figure 2H). Biochemical characterization of MV-∆M
infectivity was attempted using methods applied to the
analysis of standard, altered or chimeric MV particles
(Cathomen et al., 1998; Spielhofer et al., 1998) but failed.
This may be due in part to the limited amount of material
available, and in part to heterogeneity or fragility of the
infectivity (see below). However, by electron-microscopy
virus-like MV-∆M particles were monitored in the vicinity
of infected syncytia, but only rarely did these particles
contain ribonucleocapsid-like filaments (Figure 4F and
G). Considering these facts we refer to MV-∆M ‘infectious
units’ or ‘infectivity’ rather than to MV-∆M ‘infectious
particles’.
MV-∆M infectivity may consist of plasmalemma ves-
icles containing viral glycoproteins and ribonucleocapsids.
The production of these infectious vesicles may be
favoured by the fact that even without M protein the
viral glycoproteins partly retain clustering in membrane
microdomains (Figures 3 and 4). These microdomains may
be extruded stochastically from cells based on constitutive
exocytotic mechanisms. At late infection stages, when all
viral components are present at high concentrations, a
fraction of these glycoprotein-enriched vesicles would
contain ribonucleocapsids and behave as infectivity. A
precedent for the formation of infectious, membrane-
enveloped vesicles is available: the RNA of a Semliki
forest virus-derived replicon encoding the vesicular sto-
matitis virus glycoprotein is encapsidated in glycoprotein-
enriched particles and propagates at low titres in cultured
cells (Rolls et al., 1994).
We conclude that in the absence of M, orthodox MV
particles cannot be formed, as expected. Unexpectedly
however, MV-∆M infections propagate as efficiently as
standard infections in cultured cells, on the basis of
enhanced cell-to-cell fusion.
An M protein function in fusion control?
Can the more extensive fusion of MV-∆M-infected cells
be explained simply by extensive accumulation of viral
glycoproteins on the surface due to the lack of virus
budding? Probably not, because even in standard MV
infections budding is inefficient. Consistent with this, the
half-life of the MV glycoproteins on the cell surface is
long (~10 h; Fujinami et al., 1981) and the stability of
fully processed H proteins in standard infections and MV-
∆M infections is similar (Figure 1C and data not shown).
Similarly, an altered distribution of the viral envelope
proteins on the cell surface is unlikely to account for
enhanced cell fusion: MVs with altered envelope protein
cytoplasmic tails maintain a completely patchy distribution
of the envelope proteins but induce enhanced cell-to-cell
fusion (Cathomen et al., 1998). As a third rationale it
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could be argued that MV-∆M particles may contain many
more genomes than standard MV particles. In this case
MV-∆M infections would have a head start, and the MV-
∆M syncytia would always appear larger. Two observations
dismiss this possibility: first, even in infections starting
from genomic plasmids MV-∆M syncytia appear earlier
than standard MV syncytia. Secondly, MV-∆M syncytia
are qualitatively different: they maintain a more regular
organization of the nuclei and grow to a larger size before
loosing attachment (T.Cathomen, unpublished data).
We suggest that the association of M with the cyto-
plasmic tails of the glycoproteins may negatively influence
their fusion efficiency (Cathomen et al., 1998). Indeed, a
fusion regulatory function of the M protein was proposed
based on the analysis of an MV strain composed of a
non-resolvable mixture of highly productive, non-
fusogenic MV and a cell-associated, highly fusogenic
virus (Carrigan, 1985). Moreover, electron microscopy
observations of two other paramyxoviruses are consistent
with an M-protein-imparted fusion-refractory state of
the envelope protein complex (Buechi and Ba¨chi, 1982;
Russell and Almeida, 1984).
Interestingly, a fusion-regulatory function of the human
immunodeficiency virus (HIV) M protein has been postu-
lated on the basis of genetic data (De Mareuil et al.,
1995). Remarkably, HIV-1 variants with truncated cyto-
plasmic tails are more fusogenic than standard viruses
(Wilk et al., 1992). Moreover, removal of a short segment
from the cytoplasmic tail of the envelope protein of
two other retroviruses enhances the competence of these
envelope proteins for fusion (Brody et al., 1992; Januszeski
et al., 1997). Obviously the functions of the matrix proteins
of paramyxoviruses and retroviruses cannot be compared
directly, but it can be noted that all viruses fusing at
neutral pH may have to regulate fusion competence in
order to prevent immediate re-infection upon virus release
and to limit fusion of intracellular membranes. This
problem does not exist for viruses entering the cell via
the endocytic vacuolar system, where fusion is activated
by acidic pH (Helenius, 1995; Hernandez et al., 1996).
Brain propagation of mutated MV and SSPE
We examined the propagation of the M-less, cell-free,
highly fusogenic MV in the brain of adult mice expressing
CD46 with human-like tissue specificity and defective for
the interferon type I receptor (Mrkic et al., 1998). Not
only MV-∆M and standard MV, but also an engineered
MV with altered F and H glycoprotein cytoplasmic tails
(MV-∆tails) were tested. This virus exhibits increased cell-
to-cell fusion competence but produces particles at lower
levels than standard MV (Cathomen et al., 1998). Both
MV-∆M and MV-∆tails penetrated more deeply than stand-
ard virus into the brain parenchyma. Thus the gain in cell-
to-cell fusion competence of assembly-defective viruses
also appears to contribute to the spread of infectivity in
brain. The situation may be similar in persistent MV
infections of human brains: mutated, assembly-defective
MV do overgrow parental virus (Schmid et al., 1992;
Baczko et al., 1993). However, it must be emphasized that
the short-term infections of mouse brain differ profoundly
from SSPE, which develops over several years in humans.
The histological analysis of brains from mice inoculated
with low doses of standard MV sacrificed days or weeks
A matrix-less measles virus
p.i. is of interest: viral replication and inflammatory lesions
were observed in different parts of the parenchyma close
to regions contacting the cerebrospinal fluid. In particular,
in one of these areas, the hippocampal CA1 region, a
characteristic nerve cell loss was monitored. Remarkably,
a similar pathology was described previously in adult
BALB/c mice infected with neurotropic MV strains
(Andersson et al., 1993; Eastman et al., 1994) and in
newborn hamsters (Carrigan, 1986). In contrast, MV-∆M
or MV-∆tails infections did not induce this pathogenic
feature but penetrated more deeply than standard virus in
the brain parenchyma. It can be speculated that the
destruction of a whole specialized area of the CNS may
be lethal, whereas patchy, partial destruction of many
areas can be overcome.
An hypothetical scenario of MV propagation in human
brain may be as follows. After acute respiratory infection
and systemic spread, in a significant fraction of cases MV
may invade the CNS and replicate (ter Meulen et al.,
1983; Katayama et al., 1995). Whereas standard MVs can
be efficiently eliminated by the host immune system
(Carrigan, 1986), assembly-defective MVs may be better
tolerated and thus persist more often. These viruses, being
highly fusogenic, would propagate deep in the brain
parenchyma. In most cases, the spread of these viruses
may be limited and thus asymptomatic, as in MV-∆M-
and MV-∆tails-infected mouse brains. However, in an
exceedingly low percentage of infected human brains
continuous virus spread may cause progressive impairment




Plasmid p(1)MV-∆M containing the full-length antigenomic copy of
the M-gene-deficient MV genome was constructed in two steps: after
excision of a BglII–BclI fragment containing 960 nucleotides of the
M-gene-coding region from plasmid pePMF2 (R.Cattaneo, unpublished),
plasmid fragments were religated giving rise to peP∆MF2 (Figure 1A).
Plasmid p(1)MV-∆M was obtained by three-way ligation of a SacII–
NarI fragment of peP∆MF2 with a NarI–PacI and the PacI–SacII
fragment of p(1)MV (Radecke et al., 1995) containing the terminal MV
genome segments and the plasmid backbone.
Viruses and virus assays
MV-∆M rescued from p(1)MV-∆M, the standard tagged MV derived
from the Edmonston-B-based plasmid p(1)MV, and MV-∆tails were
propagated and purified as described previously (Radecke et al., 1995).
The biological activities of the viruses were determined by plaque assays
(Radecke et al., 1995) or by 50% end-point dilution assays (TCID50;
Cathomen et al., 1998).
RT–PCR
For RNA analysis, infected Vero cells were lysed and total RNA
isolated using RNeasy spin columns (Qiagen). Reverse transcription was
performed with M-MLV reverse transcriptase (Gibco-BRL) using specific
primers binding to the 39-terminal region of either the M gene or the
N gene, respectively. For amplification of the M gene, primers annealing
to both gene ends were used, for amplification of the N gene primers
whose 59-end is situated 475 nucleotides apart were used.
Metabolic labelling, immunoprecipitation and endo H
digestion
Metabolic labelling, immunoprecipitation and endo H digestion were
performed as previously described (Cattaneo and Rose, 1993). Briefly,
Vero cells were infected with MV or MV-∆M at an m.o.i. of 0.5 for 2 h
at 37°C. Sixteen hours p.i., cells were starved for 30 min in methionine/
cysteine-free Dulbecco’s modified Eagle’s medium (DMEM), pulsed for
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1 h in the presence of 100 µCi Tran35S-label (ICN) and, if indicated,
chased for 4 h with DMEM supplemented with 10% fetal calf serum
(DMEM-10). Immunoprecipitation was performed using a polyclonal
goat anti-MV antibody (courtesy of S.Udem).
Growth analysis
Vero cells (23105) in 15 mm wells were infected with MV or MV-∆M
at an m.o.i. of 0.01 for 2 h at 37°C. Inocula were collected to control
virus adsorption. Cells were washed twice with phosphate-buffered
saline (PBS), overlain with 500 µl DMEM-5 and incubated at 32.5°C
to favour virus release (Udem, 1984). Every 24 h cell-free and cell-
associated virus were collected and stored at –30°C. Cell-free samples
were prepared by clarifying supernatants of infected cells for 2 min at
8000 r.p.m. in an Eppendorf centrifuge. Cell-associated virus was
recovered by scraping infected cells into 500 µl DMEM-5. Infectivity
was determined by TCID50 titration.
Confocal microscopy
Infected Vero cells on glass cover-slips were double-labelled for M and
H or P and H protein. After fixation in methanol and blocking in 0.5%
bovine serum albumin (BSA) in PBS, cells were incubated with antibodies
diluted in PBS containing 0.5% Tween-20. The primary antibody
mixtures contained either a monoclonal anti-M or anti-P antibody (both
1:200; courtesy of C.O¨ rvell) and a rabbit anti-peptide serum against H
(1:200; Buchholz et al., 1996). The secondary antibody mixture consisted
of an FITC-conjugated donkey anti-mouse IgG and a donkey anti-rabbit
IgG coupled to TRITC (both 1:100; Jackson). Cover-slips were mounted
using the antifadant Citifluor AF1 (Cancer Research Campaign) and
immunoreactivity was visualized using confocal microscopy (Leica TCS
NT) in conjunction with a Leitz DM IRBE fluorescence microscope in
~0.4 µm optical sections. Image stacks, confirmed by single excitation
to prevent spill-over artefacts, were obtained in double-excitation mode
and recombined using Imaris and Selima image-processing software
(Bitplane AG, Technopark Zurich, Switzerland).
Electron microscopy
Vero cells in 24-well culture dishes were infected with MV or MV-∆M
at an m.o.i. of 0.05. After 2 days incubation at 32.5°C (syncytia formation
involved ~90% of the cells), the culture medium was removed and cells
were fixed for 1 h in 4% paraformaldehyde made in cacodylate buffer.
The cells were then rinsed three times in PBS and blocked for 30 min
in PBS containing 5% acetylated bovine serum albumin (BSAc, Aurion,
The Netherlands), 0.1% cold-water fish skin gelatine and 1% normal
goat serum. After three washes in PBS containing 0.1% BSAc (PBS–
BSAc), cells were incubated overnight at 4°C in a humid chamber with
a pool of monoclonal antibodies (courtesy of D.Gerlier) against either
H or F (diluted 1:1000 in PBS–BSAc). Cells were washed three times
in PBS–BSAc and then incubated at 4°C for 4 h with goat anti-mouse
antibodies coupled to 10-nm colloidal gold particles (1:40; Aurion).
After washing three times in PBS–BSAc and five times in PBS, the
cells were fixed consecutively in 2% glutaraldehyde made in PBS, 0.5%
osmium tetroxide and 2% uranyl acetate. Samples were then dehydrated
stepwise with increasing concentrations of ethanol and embedded in
epon. After polymerization the samples were cut into 100 nm thick
sections, recovered onto copper grids, stained with uranyl acetate and
lead citrate and then analysed under a Philips CM120 Biotwin electron
microscope at 120 kV.
Histopathology and in situ hybridization
Histopathology and in situ hybridization were basically performed as
described elsewhere (Mrkic et al., 1998). Briefly, for histopathological
analysis mice were sacrificed and the brains fixed in 4% PBS-buffered
formaldehyde. Sagittal and coronal brain sections were cut at 2 µm and
either stained with haematoxylin/eosin or luxol/fast nuclear red or
prepared immunohistochemically with rabbit anti-GFAP antibodies fol-
lowed by detection with avidin–biotin–peroxidase (VectorLabs). MV
N-specific mRNA was detected in brain sections with DIG-labelled
antisense N mRNA probes. Immunological detection and staining was
performed using a DIG nucleic acid detection kit (Boehringer Mannheim).
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